Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 91

    Lupin unveils generic version of Prozac tablets in US

    Lupin unveils generic version of Prozac tablets in US

    Medical Dialogues Bureau24 Aug 2019 9:45 AM IST
    Fluoxetine tablet is a generic version of Eli Lilly and Company's Prozac tablets in the same strengths, Lupin said.Mumba: Pharma major Lupin Limited...
    Zydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOS

    Zydus Cadila begins phase 2 trial for Saroglitazar Mg to treat NAFLD in women with PCOS

    Medical Dialogues Bureau24 Aug 2019 9:35 AM IST
    Research suggests that in women with polycystic ovary syndrome (PCOS), there is increased risk for non-alcoholic fatty liver disease, Zydus Cadila...
    Oklahoma judge to rule in opioid lawsuit against JnJ

    Oklahoma judge to rule in opioid lawsuit against JnJ

    Medical Dialogues Bureau24 Aug 2019 9:10 AM IST
    Lawyers for the state called JnJ an opioid "kingpin" and contended its marketing efforts created a public nuisance in the form of the opioid crisis as...
    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
    Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
    Glenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancer

    Glenmark receives USFDA nod for generic version of Faslodex Injection to treat breast cancer

    Medical Dialogues Bureau23 Aug 2019 11:52 AM IST
    The approved product, Fulvestrant injection is a generic version of AstraZeneca's Faslodex Injection in the same strength, Glenmark Pharma said in a...
    Granules India gets 2 USFDA observations for Chantilly facility

    Granules India gets 2 USFDA observations for Chantilly facility

    Medical Dialogues Bureau23 Aug 2019 11:46 AM IST
    "The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
    Biocon wins European nod for Malaysia insulin facility

    Biocon wins European nod for Malaysia insulin facility

    Medical Dialogues Bureau23 Aug 2019 9:30 AM IST
    Biocon Sdn Bhd, which operates Asia's largest integrated insulin facility, has received the Certificate of Good Manufacturing Practices. The site was...
    AstraZeneca diabetes drug Farxiga meets goal in heart failure trial

    AstraZeneca diabetes drug Farxiga meets goal in heart failure trial

    Medical Dialogues Bureau23 Aug 2019 9:15 AM IST
    Farxiga, already one of AstraZeneca’s top 10 drugs by sales, met the main goal of the so-called DAPA-HF trial, which tested the medicine in addition...
    Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day

    Nabriva Therapeutics 2 pneumonia antibiotic versions priced at over Rs 14000 per day

    Medical Dialogues Bureau23 Aug 2019 9:00 AM IST
    The drug Xenleta, also called lefamulin, works by interfering with the bacteria's ability to replicate. It's the first drug by Nabriva Therapeutics to...
    Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina

    Zydus Cadila gets USFDA nod for Ranolazine Extended-Release tablets to treat chronic angina

    Medical Dialogues Bureau22 Aug 2019 10:00 AM IST
    The company has received approval for Ranolazine Extended-Release tablets from the United States Food and Drug Administration (USFDA) to market the...
    Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

    Lupin to sell Japanese injectables business to Abu-Dhabi based Neopharma group

    Medical Dialogues Bureau22 Aug 2019 9:50 AM IST
    "Under the terms of the agreement, Lupin has agreed to sell all the issued and outstanding share capital in Kyowa Criticare Co Ltd to neo-ALA Co Ltd....
    Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford

    Pfizer infuses Rs 3597 crore to expand gene therapy plant in Sanford

    Medical Dialogues Bureau22 Aug 2019 9:30 AM IST
    The investment will add additional capacity and capabilities to a facility that makes some of Pfizer's most closely watched experimental...
    PrevNext

    Popular Stories

    OncoStem Diagnostics named

    OncoStem Diagnostics named 'Best Innovation- Cancer Risk Assessment' by NASSCOM Life sciences and...

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    Coronavirus: CDSCO issues guidelines to be followed while visiting CDSCO office.

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Religare Enterprises to divest stake in arm to Kedaara for Rs 200 crore

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    Biocon Biologics appoints M B Chinappa as Chief Financial Officer

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok